Literature DB >> 12149289

Bisphosphonates and tumor burden.

Gregory R Mundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12149289     DOI： 10.1200/JCO.2002.20.15.3191

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.

Authors:  Nirmeen A Sabry; Emad E Habib
Journal:  Med Oncol       Date:  2010-03-05       Impact factor: 3.064

2.  Should all adjuvant breast cancer patients receive a bisphosphonate?

Authors:  David A Cameron
Journal:  Breast Cancer Res       Date:  2003-10-01       Impact factor: 6.466

3.  Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws.

Authors:  Farzin Sarkarat; Mohammad Hosein Kalantar Motamedi; Jahanfar Jahanbani; Dena Sepehri; Roozbeh Kahali; Zahra Nematollahi
Journal:  Trauma Mon       Date:  2014-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.